Compare · ACN vs EUCRU

ACN vs EUCRU

Side-by-side comparison of Accenture plc (ACN) and Eucrates Biomedical Acquisition Corp. (EUCRU): market cap, price performance, sector, and recent activity on the wire.

Summary

  • ACN operates in Consumer Discretionary, while EUCRU operates in Finance - the two are in different parts of the market.
  • ACN carries a market cap of $146.17B.
  • ACN has hit the wire 37 times in the past 4 weeks while EUCRU has been quiet.
  • ACN has more recent analyst coverage (25 ratings vs 0 for EUCRU).
MetricACNEUCRU
Company
Accenture plc
Eucrates Biomedical Acquisition Corp.
Price
-
-
Market cap
$146.17B
-
1M return
-9.03%
-
1Y return
-9.20%
-
Industry
Business Services
Business Services
Exchange
NYSE
NASDAQ
IPO
2001
2020
News (4w)
37
0
Recent ratings
25
0
ACN

Accenture plc

Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company also provides outsourcing services. It serves communications, media, high tech, software, and platform companies; banking, capital market, and insurance industries; and consumer goods, retail, travel services, industrial, and life science industries, as well as clients in health, public service, chemicals and natural resources, energy, and utility sectors. Accenture plc has alliance relationships with Adobe, Alibaba, Amazon Web Services, Blue Yonder, Cisco, Dell, Google, HPE, IBM RedHat, Microsoft, Oracle, Pegasystems, Salesforce, SAP, ServiceNow, VMWare, Workday, Massachusetts Institute of Technology, Institut Polytechnique de Paris, CNH Industrial, and Reactive Technologies. It has an agreement with Duke Energy Corporation for the development of a technology platform designed to measure actual baseline methane emissions from natural gas distribution systems. The company was incorporated in 2009 and is based in Dublin, Ireland.

EUCRU

Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Latest ACN

Latest EUCRU

No recent items for Eucrates Biomedical Acquisition Corp..